Therapeutic guidelines for treatment of HIV infections depend on the presence of symptoms, viral load, CD4+ T-cell counts, and other special circumstances. The general consensus is that all patients with symptomatic HIV disease should be given antiretroviral therapy. In asymptomatic, HIV-infected individuals, therapy should be used in the event of a high viral titer or declining CD4 T-cell count (fewer than 200 cells/mm3). In the setting of an intermediate CD4+ T-cell count; i.e., between 200 and 350 cells/mm3, the decision to initiate therapy should be made in consultation with the patient but should be strongly considered if the viral load is increasing, the cell count is decreasing, or both
Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...
Background: Zidovudine therapy is of benefit in the treatment of symptomatic and asymptomatic human ...
OBJECTIVE: To evaluate CD4 cell count-driven strategies for the initiation of highly active antiretr...
when to initiate highly active antiretroviral therapy (HAART) in adults is based on the 2002 WHO gui...
Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0...
Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0...
We assessed whether low CD4 count and high viral load (VL) affect the response to currently preferre...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
This study prospectively assessed the impact of treatment modality, virus load, and CD4 cell count o...
Twenty-four years after the first cases of AIDS were reported, it remains unclear when therapy for H...
BACKGROUND: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...
This study prospectively assessed the impact of treatment modality, virus load, and CD4 cell count o...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
BackgroundThe World Health Organization (WHO) Consolidated antiretroviral therapy (ART) guidelines s...
Objective: Treatment guidelines recommend initiation of therapy for individuals experiencing rapid ...
Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...
Background: Zidovudine therapy is of benefit in the treatment of symptomatic and asymptomatic human ...
OBJECTIVE: To evaluate CD4 cell count-driven strategies for the initiation of highly active antiretr...
when to initiate highly active antiretroviral therapy (HAART) in adults is based on the 2002 WHO gui...
Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0...
Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0...
We assessed whether low CD4 count and high viral load (VL) affect the response to currently preferre...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
This study prospectively assessed the impact of treatment modality, virus load, and CD4 cell count o...
Twenty-four years after the first cases of AIDS were reported, it remains unclear when therapy for H...
BACKGROUND: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...
This study prospectively assessed the impact of treatment modality, virus load, and CD4 cell count o...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
BackgroundThe World Health Organization (WHO) Consolidated antiretroviral therapy (ART) guidelines s...
Objective: Treatment guidelines recommend initiation of therapy for individuals experiencing rapid ...
Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...
Background: Zidovudine therapy is of benefit in the treatment of symptomatic and asymptomatic human ...
OBJECTIVE: To evaluate CD4 cell count-driven strategies for the initiation of highly active antiretr...